Jonathon Mahlow
No Rating Available
(Learn About Our Rating System)

Jonathon Mahlow, MD

Languages spoken: English

  • Dr. Mahlow is a staff pathologist at ARUP and an assistant professor of pathology at the University of Utah School of Medicine. He received his MD from Wayne State School of Medicine in Detroit MI and completed his anatomic and clinical pathology residency training at the Cleveland Clinic Foundation in Cleveland OH. Subsequently, he completed a fellowship in surgical pathology at the University of Utah. Dr. Mahlow is a member of several professional societies, including the United States and Canadian Academy of Pathology, and the American Society for Clinical Pathology.

    Dr. Mahlow’s subspecialty areas of expertise and research interests include genitourinary pathology, breast pathology, and cardiac pathology.

    Specialties

    • Breast Pathology
    • Cardiac Pathology
    • Pathology, Anatomical
    • Surgical Pathology
    • Urologic Pathology

    Board Certification

    American Board of Pathology (Anatomic & Clinical)

  • Dr. Mahlow is a staff pathologist at ARUP and an assistant professor of pathology at the University of Utah School of Medicine. He received his MD from Wayne State School of Medicine in Detroit MI and completed his anatomic and clinical pathology residency training at the Cleveland Clinic Foundation in Cleveland OH. Subsequently, he completed a fellowship in surgical pathology at the University of Utah. Dr. Mahlow is a member of several professional societies, including the United States and Canadian Academy of Pathology, and the American Society for Clinical Pathology.

    Dr. Mahlow’s subspecialty areas of expertise and research interests include genitourinary pathology, breast pathology, and cardiac pathology.

    Board Certification and Academic Information

    Academic Departments Pathology -Primary
    Board Certification
    American Board of Pathology (Anatomic & Clinical)

    Education history

    Fellowship General Surgical Pathology - University of Utah School of Medicine Fellow
    Anatomic and Clinical Pathology - Pathology and Laboratory Medicine Institute, Cleveland Clinic Resident
    Professional Medical Medicine - Wayne State University School of Medicine M.D.
    Chemistry - University of Michigan Research Fellow
    Undergraduate Biochemistry - University of Michigan B.S.
    Undergraduate Chemistry - University of Michigan B.S.Chem

    Selected Publications

    Journal Article

    1. Brownson KE, Flores-Huidobro Martinez A, Ganbayar J, Sorensen LM, Darelli-Anderson AM, Prathibha S, Hoven N, Nansalmaa E, Mahlow J, Pushkin B, Potter D, Tuttle T, Price RR (2023). Development of an International Virtual Multidisciplinary Tumor Board for Breast Cancer in Mongolia. J Surg Res, 295, 776-782. (Read full article)
    2. Sangoi AR, Tsai H, Harik L, Mahlow J, Tretiakova M, Williamson SR, Hirsch MS (2024). Vascular, adipose tissue, and/or calyceal invasion in clear cell tubulopapillary renal cell tumour: potentially problematic diagnostic scenarios. Histopathology. (Read full article)
    3. Mahlow J, Barry M, Albertson DJ, Jo YJ, Balatico M, Seasor T, Gebrael G, Kumar SA, Sayegh N, Tripathi N, Agarwal N, Swami U, Sirohi D (2024). Histologic patterns in prostatic adenocarcinoma are not predictive of mutations in the homologous recombination repair pathway. Hum Pathol, 144, 28-33. (Read full article)
    4. Wilcock D, Sirohi D, Albertson D, Cleary AS, Coleman JF, Jedrzkiewicz J, Mahlow J, Ruano AL, Gulbahce HE (2023). Clinicopathologic Features of Breast Carcinoma With 2018 American Society of Clinical Oncology/College of American Pathologists Fluorescence In Situ Hybridization Group 3 (Human Epidermal Growth Factor Receptor 2 Chromosome 17 Centromere Ratio <2.0 and Average Human Epidermal Growth Factor Receptor 2 Copy Number ≥6.0) Breast Cancers. Arch Pathol Lab Med. (Read full article)
    5. Tausinga T Snyder L Mahlow J Agarwal C Hotaling J McCormick B (2023). Incidental discovery of seminoma after simple orchiectomy in transgender individuals: A case series. J Urol Res, 8(2), 22-29.
    6. Repetto F, Sirohi D, Greipp P, Mahlow J (2023). Incidental Detection of TFEB-Amplified Renal Cell Carcinoma by Colocated Gene Amplification of CCND3 (6p21): A Case Report and Review of the Literature. Int J Surg Pathol, 10668969231185081. (Read full article)
    7. Wilcock DM, Moore KH, Rowe L, Mahlow J, Jedrzkiewicz J, Cleary AS, Lomo L, Ruano AL, Gering M, Bradshaw D, Maughan M, Tran P, Burlingame J, Davis R, Affolter K, Albertson DJ, Adelhardt P, Kim JT, Coleman JF, Deftereos G, Gulbahce EH, Sirohi D (2023). Quantitative Imaging Analysis Fluorescence In Situ Hybridization Validation for Clinical HER2 Testing in Breast Cancer. Arch Pathol Lab Med. (Read full article)
    8. McMurtry V, Mahlow J, Coleman JF, Deftereos G, Jattani R, Bastien RRL, Durtschi J, Jarboe E, Lomo L, Sirohi D (2022). Morphologic Characteristics and Mutational Analysis of Fumarate Hydratase Deficient Kidney and Smooth Muscle Tumors. Am J Clin Pathol, 159(2), 164-171. (Read full article)
    9. Jeffrey Vehawn, Jonathon Mahlow, Jayant Agarwal, Christopher Dechet, Alejandro Sanchez (2022). Case of testicular nonseminomatous germ cell tumor cancer soft tissue seeding after inguinal orchiectomy. Urol Case Rep.
    10. Sirohi D, Chipman J, Barry M, Albertson D, Mahlow J, Liu T, Raps E, Haaland B, Sayegh N, Li H, Rathi N, Sharma P, Agarwal N, Knudsen B (2022). Histologic Growth Patterns in Clear Cell Renal Cell Carcinoma Stratify Patients into Survival Risk Groups. Clin Genitourin Cancer, 20(3), e233-e243. (Read full article)
    11. Kukull B, Mahlow J, Hale G, Perry LJ (2021). Whipple's disease: a fatal mimic. Autops Case Rep, 11, e2020237. (Read full article)
    12. Mahlow J, Goold EA, Jedrzkiewicz J, Gulbahce HE (2020). What to Expect From the New ASCO/CAP Guideline Recommendations for Hormone Receptor Testing in Breast Cancer: A National Reference Laboratory Experience. Appl Immunohistochem Mol Morphol, 29, 245-250. (Read full article)

    Review

    1. Mahlow J, Gupta S (2024). Pathology Focused Review of Morphologic Subtypes and Molecular Variants of Urothelial Carcinoma With an Emphasis on Clinical/Treatment Relevance. [Review]. Urol Oncol. (Read full article)

    Case Report

    1. Mahlow J, Sanchez A, Barry M, Sirohi D (2022). Composite pheochromocytoma/paraganglioma-ganglioneuroma with a germline SDHC mutation: a first of its kind case report. Histopathology, 81(5), 682-685. (Read full article)